{"schema_version":"secwatch.filing_event.v1","accession":"0001081188-22-000006","form_type":"8-K","ticker":"GEGP","cik":"0001081188","company_name":"GOLD ENTERPRISE GROUP INC","filed_at":"2022-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.916782+00:00","generated_at":"2026-06-24T06:17:53.390529+00:00","sec_items":["1.01","3.03","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"medium","headline":"Gold Entertainment to issue 100K Series B preferred shares for controlling stake in DEVON Testing","bullets":["Issued 100,000 Series B Preferred shares as payment to acquire controlling shares of DEVON MEDICAL PRODUCTS, INC.","Authorized Preferred B shares increased to 500,000; amended articles filed with Florida.","Agreement effective February 1, 2022; reported on Form 8-K dated July 30, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001081188-22-000006","json":"https://secwatch.observer/filing/0001081188-22-000006.json","markdown":"https://secwatch.observer/filing/0001081188-22-000006.md","text":"https://secwatch.observer/filing/0001081188-22-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1081188/000108118822000006/0001081188-22-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1081188/000108118822000006/8k_devon2022.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T06:17:53.390529+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}